AN

Advanced Nanotherapies

Next Generation Drug-Coated Balloons

Santa Clara, United States · Founded 2018 · $36.3M raised

Headquarters
Santa Clara
Founded
2018
Business Model
B2B
Total Funding
$36.3M
Last Round
$31.0M Series BJun 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Advanced NanoTherapies (ANT) is a Santa Clara, California-based clinical-stage medical device company developing SirPlux Duo, a next-generation drug-coated balloon (DCB) therapy for coronary and peripheral artery disease. Powered by ANT's proprietary functionalized nanoparticle drug delivery platform, SirPlux Duo is the only DCB designed to deliver two synergistic drugs, Sirolimus and Paclitaxel, simultaneously and release them in-tissue over the long term to achieve stent-like patency without a permanent stent. The FDA granted SirPlux Duo Breakthrough Device designation for small-vessel coronary artery disease, and ANT closed an oversubscribed $31 million Series B financing in 2026 to advance its clinical program.

Summary

Advanced Nanotherapies is a Healthcare company based in Santa Clara, United States, founded in 2018. It has raised $36.3M in total across 2 rounds, most recently a $31.0M Series B round in Jun 2026. Investors include S3 Ventures.

Funding History

Series BSeries BJun 2026
$31.0M

Sign up to see all 2 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Advanced Nanotherapies on Indexed.vc
<a href="https://indexed.vc/companies/advanced-nanotherapies"><img src="https://indexed.vc/api/badge/company/advanced-nanotherapies" alt="Advanced Nanotherapies on Indexed.vc" width="260" height="76" /></a>